Literature DB >> 10818514

Can PET data differentiate Alzheimer's disease from vascular dementia?

K Nagata1, H Maruya, H Yuya, H Terashi, Y Mito, H Kato, M Sato, Y Satoh, Y Watahiki, Y Hirata, E Yokoyama, J Hatazawa.   

Abstract

The present study endeavored to differentiate Alzheimer's disease (AD) from vascular dementia (VaD) by comparing the metabolic and hemodynamic parameters. Positron emission tomographic (PET) studies were carried out in 13 patients with probable AD and 20 patients with VaD. PET findings were not included in the diagnostic criteria of AD or VaD. Using oxygen-15 labeled compounds, cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO2), oxygen extraction fraction (OEF), cerebral blood volume, and vascular transit time (VTT) were measured quantitatively during the resting state. To evaluate vascular reactivity (VR), CBF was also measured during 7% CO2 inhalation. Regional CBF from the parietal cortex positively correlated with the neuropsychological scores in both AD and VaD groups. The typical parietotemporal pattern of hypoperfusion and hypometabolism was observed in the AD group, whereas the frontal lobe including the cingulate and superior frontal gyri were predominantly affected in the VaD group. The occipital cortex was preserved in both groups. A significant increase of the OEF was found in the parietotemporal areas in the AD group. No significant prolongation was seen with VTT. There was a marked difference in VR between the two groups: VR was depleted in the VaD group, whereas VR was normal in the AD group. The increased OEF with preserved vascular reserve seen in AD may implicate participation of a vascular factor in the pathogenesis of AD, possibly at the capillary level. Thus, PET provides important functional information in discriminating AD from VaD by comparing the patterns of hypoperfusion and/or hypometabolism, and in the understanding of the underlying hemodynamic pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818514     DOI: 10.1111/j.1749-6632.2000.tb06375.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

1.  Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow.

Authors:  Bich-Ngoc-Thanh Tang; Satoshi Minoshima; Jean George; Annie Robert; Christian Swine; Patrice Laloux; Thierry Vander Borght
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-01       Impact factor: 9.236

2.  On the sensitivity of ASL MRI in detecting regional differences in cerebral blood flow.

Authors:  Sina Aslan; Hanzhang Lu
Journal:  Magn Reson Imaging       Date:  2010-04-27       Impact factor: 2.546

3.  Ultrasonographic measurement of cerebral blood flow, cerebral circulation time and cerebral blood volume in vascular and Alzheimer's dementia.

Authors:  Stephan J Schreiber; Florian Doepp; Eike Spruth; Ute A Kopp; José M Valdueza
Journal:  J Neurol       Date:  2005-09-12       Impact factor: 4.849

Review 4.  Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.

Authors:  Peter J Nestor; Daniele Altomare; Cristina Festari; Alexander Drzezga; Jasmine Rivolta; Zuzana Walker; Femke Bouwman; Stefania Orini; Ian Law; Federica Agosta; Javier Arbizu; Marina Boccardi; Flavio Nobili; Giovanni Battista Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-07       Impact factor: 9.236

5.  Differentiating Alzheimer's disease from subcortical vascular dementia with the FAB test.

Authors:  Hiroaki Oguro; Shuhei Yamaguchi; Satoshi Abe; Yuri Ishida; Hirokazu Bokura; Shotai Kobayashi
Journal:  J Neurol       Date:  2006-10-13       Impact factor: 4.849

6.  Age-associated reductions in cerebral blood flow are independent from regional atrophy.

Authors:  J Jean Chen; H Diana Rosas; David H Salat
Journal:  Neuroimage       Date:  2010-12-16       Impact factor: 6.556

7.  [Alzheimer's disease and vascular dementia. Determination of atrophy of the corpus callosum and cerebral cortex].

Authors:  T Möller; C Born; M F Reiser; H-J Möller; H Hampel; S J Teipel
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

8.  Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity.

Authors:  Jinsoo Uh; Kelly Lewis-Amezcua; Kristin Martin-Cook; Yamei Cheng; Myron Weiner; Ramon Diaz-Arrastia; Michael Devous; Dinggang Shen; Hanzhang Lu
Journal:  Neurobiol Aging       Date:  2009-02-05       Impact factor: 4.673

9.  Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.

Authors:  N Schuff; A A Capizzano; A T Du; D L Amend; J O'Neill; D Norman; W J Jagust; H C Chui; J H Kramer; B R Reed; B L Miller; K Yaffe; M W Weiner
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

10.  Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging.

Authors:  Norbert Schuff; Shinji Matsumoto; Joseph Kmiecik; Colin Studholme; Antao Du; Frank Ezekiel; Bruce L Miller; Joel H Kramer; William J Jagust; Helen C Chui; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2009-11       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.